和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02256 和誉-B

休市中 09-04 16:08:03

8.765

-0.160

-1.79%

最高9.160	最低8.720	成交量146.80万
今开9.010	昨收8.925	日振幅4.93%
总市值62.85亿	流通市值62.85亿	总股本7.17亿
成交额1,316万	换手率0.20%	流通股本7.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":8.765,"timestamp":1788509283005,"preClose":8.925,"halted":0,"volume":1468000,"delay":0,"changeRate":-0.017927170868347355,"floatShares":717000000,"shares":717000000,"eps":0.088442,"marketStatus":"休市中","change":-0.16,"latestTime":"09-04 16:08:03","open":9.01,"high":9.16,"low":8.72,"amount":13161835,"amplitude":0.0493,"askPrice":8.8,"askSize":1000,"bidPrice":8.765,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.749,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":7,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":8.925,"openAndCloseTimeList":[[1788485400000,1788494400000],[1788498000000,1788508800000]],"volumeRatio":1.307678603172581,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02256/tweets","defaultTab":"tweets","newsList":[{"id":"2664789817","title":"和誉-B(02256.HK)遭Allianz SE减持5.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664789817","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664789817?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:27","pubTimestamp":1788359221,"startTime":"0","endTime":"0","summary":"格隆汇9月2日丨根据联交所最新权益披露资料显示，2026年8月31日，和誉-B(02256.HK)遭Allianz SE在场内以每股均价9.8065港元减持5.6万股，涉资约54.92万港元。\r\n\r\n　　减持后，Allianz SE最新持股数目为5081.5万股，持股比例由7.01%下降至7.00%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/02/20260902905125.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/02/20260902905125.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260902/32358337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2476274308.USD","LU2778985437.USD","02256","ALIZY","LU2476274720.SGD","IE00BPRC5H50.USD","IE00B543WZ88.USD","ALIZF","LU2488822045.USD","BK1161","IE00B5MMRT66.SGD","BK4117"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139662009","title":"和誉-B：9月2日回购5万股，耗资约44.32万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139662009","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139662009?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:56","pubTimestamp":1788350182,"startTime":"0","endTime":"0","summary":"和誉-B于2026年9月2日发布翌日披露报表显示，公司于当日通过香港联交所场内回购普通股50,000股，约占该次回购前已发行股本0.00697%。本次回购价格区间为每股8.74港元至8.97港元，总金额约为44.32万港元。回购完成后，公司已发行股份数目为717,491,350股，库藏股数目增至8,714,000股，已发行股份总数保持不变，为726,205,350股。根据公告披露，本次回购后，公司在30天内不得未经联交所批准发行新股或出售、转让任何库藏股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B：9月2日回购5万股，耗资约44.32万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819664","title":"和誉-B(02256)9月2日斥资44.32万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819664","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664819664?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:51","pubTimestamp":1788349897,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年9月2日斥资44.32万港元回购5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2476274720.SGD","IE00B5MMRT66.SGD","BK1161","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2476274308.USD","LU2488822045.USD","02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183028145","title":"和誉-B：Allianz SE减持，好仓比例降至7.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183028145","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183028145?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:24","pubTimestamp":1788341083,"startTime":"0","endTime":"0","summary":"Allianz SE于2026年8月31日以每股均价9.8065港元卖出和誉-B股份5.60万股，涉资约54.92万港元。Allianz SE此次减持前持有和誉-B好仓5087.10万股，占比7.01%；减持后持股量为5081.50万股，好仓比例降至7.0%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856841","title":"Allianz SE增持和誉-B(02256)32万股 每股作价约9.82港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856841","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664856841?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:46","pubTimestamp":1788263217,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，8月27日，Allianz SE增持和誉-B(02256)32万股，每股作价9.8244港元，总金额约为314.38万港元。增持后最新持股数目为5087.1万股，最新持股比例为7.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ALIZF","LU2778985437.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","EWH","LU2476274308.USD","02256","ALIZY","BK4117","BK1161","LU2488822045.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173578966","title":"和誉-B 9月1日回购50,000股股份，总额约44.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173578966","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173578966?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:04","pubTimestamp":1788260649,"startTime":"0","endTime":"0","summary":"和誉开曼有限责任公司于2026年9月1日刊发翌日披露报表，公告当日于香港联交所场内回购50,000股普通股，占前一交易日已发行股份总数约0.00697%。本次回购每股价格区间为8.765港元至8.875港元，合共耗资441,210港元，折合约44.12万港元。公司此前于2026年5月20日获股东大会授予购回股份的授权，授权总数为71,646,135股，至今已在不同交易所累计购回920,000股，约占授权通过日公司已发行股份总数的0.12841%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B 9月1日回购50,000股股份，总额约44.12万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853030","title":"和誉-B(02256.HK)9月1日斥资44.12万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853030","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664853030?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:01","pubTimestamp":1788260516,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","LU2778985437.USD","LU2476274308.USD","LU2488822045.USD","02256","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU2476274720.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188523748","title":"和誉-B：Allianz SE增持，好仓比例升至7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188523748","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188523748?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:13","pubTimestamp":1788254010,"startTime":"0","endTime":"0","summary":"Allianz SE于2026年8月27日以每股均价9.8244港元买入和誉-B股份32.00万股，涉资约314.38万港元。Allianz SE此次增持前持有和誉-B好仓5055.10万股，占比6.96%；增持后持股量为5087.10万股，好仓比例升至7.01%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121855404","title":"和誉-B更新8月股份变动月报表 股本总数保持726,205,350股不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1121855404","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121855404?lang=zh_cn&edition=full","pubTime":"2026-09-01 16:38","pubTimestamp":1788251910,"startTime":"0","endTime":"0","summary":"2026年9月1日，02256·和誉-B发布2026年8月股份变动月报表。根据公告，截至2026年8月31日，公司法定/注册股数仍为5,000,000,000股，面值为每股0.00001美元，法定/注册股本总额维持50,000美元，不存在增减变动。报告期末，公司已发行普通股数量为717,591,350股，库存股份数量为8,614,000股，合计726,205,350股，与上月底保持一致。当月已回购普通股310,000股，并将所回购股份转为库存股份，股本总数保持不变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102453799","title":"和誉-B：8月31日回购15万股股份，耗资约135.88万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102453799","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102453799?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:46","pubTimestamp":1788176796,"startTime":"0","endTime":"0","summary":"和誉开曼有限责任公司于2026年8月31日发布公告，披露当日于香港联交所场内回购15万股普通股。此次回购股份占该公司当日前已发行股本约0.0209%，每股回购价格介乎每股8.89港元至9.875港元，总涉资1,358,825港元。根据公告，此次交易完成后，和誉开曼有限责任公司已发行股份总数变动为717,591,350股，库藏股数增至8,614,000股。同时，购回授权于2026年5月20日获通过，公司可回购股份的总数为71,646,135股，截至公告日已回购的股份总数为870,000股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B：8月31日回购15万股股份，耗资约135.88万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070137","title":"和誉-B(02256)8月31日斥资135.9万港元回购15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070137","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663070137?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:38","pubTimestamp":1788176295,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年8月31日斥资135.9万港元回购15万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","02256","IE00B543WZ88.USD","BK1161","LU2488822045.USD","LU2476274308.USD","LU2476274720.SGD","LU2778985437.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663256870","title":"港股异动 | 和誉-B(02256)高开逾6% ABSK211的I期临床试验完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2663256870","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663256870?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:26","pubTimestamp":1788139577,"startTime":"0","endTime":"0","summary":"消息面上，8月31日，和誉-B发布公告，公司的附属公司上海和誉生物医药科技有限公司宣布其口服、高效力且广泛覆盖多种KRAS改变的小分子pan-KRAS抑制剂ABSK211用于治疗携带KRAS基因改变的晚期实体瘤患者的I期临床试验已完成首例患者给药。临床前研究结果显示，ABSK211在单药及联合治疗场景中均展现出积极的抗肿瘤活性及良好的选择性，有望为携带KRAS基因改变的实体瘤患者提供新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BMED","BK4588","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2476274308.USD","BK1161","IBBJ","PSYK","MDTX","KCAI","BK4585","LU2476274720.SGD","LU2778985437.USD","IBBQ","IE00BPRC5H50.USD","02256","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663724028","title":"和誉-B(02256)：新型pan-KRAS抑制剂ABSK211I期临床试验完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2663724028","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663724028?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:20","pubTimestamp":1788135636,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，公司的附属公司上海和誉生物医药科技有限公司(“和誉医药”)宣布其口服、高效力且广泛覆盖多种KRAS改变的小分子pan-KRAS抑制剂ABSK211用于治疗携带KRAS基因改变的晚期实体瘤患者的I期临床试验已完成首例患者给药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BPRC5H50.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2488822045.USD","LU2476274720.SGD","PSYK","LU2778985437.USD","LU2476274308.USD","BMED","02256","IBBJ","MDTX","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129340434","title":"和誉-B（02256）披露：口服pan-KRAS抑制剂ABSK211在I期临床完成首例给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1129340434","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129340434?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:05","pubTimestamp":1788134732,"startTime":"0","endTime":"0","summary":"2026年8月31日，和誉-B（02256）发布自愿性公告称，其附属公司上海和誉生物医药科技有限公司的口服小分子pan-KRAS抑制剂ABSK211已在治疗携带KRAS基因改变的晚期实体瘤I期临床试验中完成首例患者给药。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662093204","title":"和誉-B(02256.HK)8月28日斥资29.07万港元回购3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662093204","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662093204?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:59","pubTimestamp":1787921978,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","02256","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2476274720.SGD","BK1161","LU2488822045.USD","LU2778985437.USD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133026239","title":"和誉-B回购3万股股份，总额约29.07万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133026239","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133026239?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:15","pubTimestamp":1787919333,"startTime":"0","endTime":"0","summary":"和誉-B于2026年8月28日发布公告，披露当日已在香港联交所场内回购30,000股股份，占该公司回购前已发行股本约0.00418%。回购价格介乎每股9.635港元至9.755港元，合计动用约29.07万港元。本次回购完成后，和誉-B已发行股本由2026年8月27日的717,771,350股减少至717,741,350股，同时库存股数量由8,434,000股增至8,464,000股。该公司曾于2026年5月20日通过购回授权，授权购回股份总数为71,646,135股，公告显示公司已在香港联交所及其他证券交易所购回合计720,000股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B回购3万股股份，总额约29.07万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145819837","title":"和誉-B（02256）拟更名为“和誉医药” 9月17日召开股东特别大会表决","url":"https://stock-news.laohu8.com/highlight/detail?id=1145819837","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145819837?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:36","pubTimestamp":1787906195,"startTime":"0","endTime":"0","summary":"香港上市公司和誉-B公告，将于2026年9月17日10:00在上海市浦东新区张江高科园区环科路515号1号楼12B林德厅召开股东特别大会。该议案获通过后，名称变更自取得开曼群岛公司注册处处长签发的更名证书之日起生效。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117832018","title":"和誉-B回购3万股股份，涉资约29.79万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117832018","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117832018?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:16","pubTimestamp":1787833011,"startTime":"0","endTime":"0","summary":"和誉开曼有限责任公司于2026年8月27日发布公告，披露当日在香港联交所场内回购3万股普通股，约占之前已发行股本总数717,801,350股的0.00418%。每股回购价格区间为每股9.81港元至10.39港元，总耗资约297,935港元。本次回购后，公司已发行股本总数维持726,205,350股，其中库藏股数量增至8,434,000股，已发行股本则降至717,771,350股。公司于2026年5月20日获股东批准购回授权，可回购股份总数为71,646,135股。公司在公告中确认，所进行的回购符合香港联交所上市规则及相关法例。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B回购3万股股份，涉资约29.79万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191716509","title":"和誉-B：8月26日回购5万股，涉资约49.64万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191716509","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191716509?lang=zh_cn&edition=full","pubTime":"2026-08-26 21:15","pubTimestamp":1787750153,"startTime":"0","endTime":"0","summary":"和譽開曼有限責任公司于2026年8月26日公告回购股份。本次回购涉及50,000股普通股，占回购前公司已发行股本约0.00697%。回购价格区间介乎每股9.805港元至10.1港元，总金额496,370港元。公告显示，购回授权已于2026年5月20日获股东大会批准，授权范围内可回购71,646,135股股份，截至目前公司累计回购660,000股。公司同时声明，已依照香港联合交易所有限公司证券上市规则及相关法律规定履行必要程序。公告由联席公司秘书张菡兮签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"和誉-B：8月26日回购5万股，涉资约49.64万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662712896","title":"和誉-B(02256)8月26日斥资49.64万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662712896","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662712896?lang=zh_cn&edition=full","pubTime":"2026-08-26 21:13","pubTimestamp":1787750002,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年8月26日，该公司斥资49.64万港元回购5万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","02256","IE00B543WZ88.USD","BK1161","LU2488822045.USD","LU2476274308.USD","LU2476274720.SGD","LU2778985437.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbisko.com","stockEarnings":[{"period":"1week","weight":-0.0545},{"period":"1month","weight":-0.1322},{"period":"3month","weight":-0.0293},{"period":"6month","weight":-0.2622},{"period":"1year","weight":-0.5079},{"period":"ytd","weight":-0.3263}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0276},{"period":"6month","weight":-0.0041},{"period":"1year","weight":0.0236},{"period":"ytd","weight":0.0008}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和誉开曼有限责任公司是一家临床阶段生物制药公司。该公司致力于发现和开发创新差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011和 ABSK091，以及12款其他在研产品。ABSK011是一种强效且高选择性的成纤维细胞生长因子受体4(FGFR4) 小分子抑制剂。ABSK091 是一种分子靶向候选产品，也是 FGFR亚型 1、2和3的强效和选择性抑制剂。该公司的产品主要用于肝细胞癌(HCC)、尿路上皮癌(UC) 和胃癌(GC)。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.122249},{"month":2,"riseRate":0.8,"avgChangeRate":0.040621},{"month":3,"riseRate":0.4,"avgChangeRate":0.033777},{"month":4,"riseRate":0.4,"avgChangeRate":0.005698},{"month":5,"riseRate":0.2,"avgChangeRate":-0.025571},{"month":6,"riseRate":0.6,"avgChangeRate":0.025986},{"month":7,"riseRate":0.6,"avgChangeRate":0.025539},{"month":8,"riseRate":0.4,"avgChangeRate":0.067354},{"month":9,"riseRate":0.6,"avgChangeRate":0.032374},{"month":10,"riseRate":0.5,"avgChangeRate":-0.043137},{"month":11,"riseRate":0.6,"avgChangeRate":0.159978},{"month":12,"riseRate":0,"avgChangeRate":-0.092694}],"exchange":"SEHK","name":"和誉-B","nameEN":"ABBISKO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和誉-B,02256,和誉-B股票,和誉-B股票老虎,和誉-B股票老虎国际,和誉-B行情,和誉-B股票行情,和誉-B股价,和誉-B股市,和誉-B股票价格,和誉-B股票交易,和誉-B股票购买,和誉-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}